Key Responsibilities & Operational Scope

In this position at Eucalyptus, your primary deliverables and day-to-day focus areas include:

• Strategy & Market Development (Japan)
• Lead clinical input for new product launches and market expansion in Japan
• Shape and continuously improve Japan-specific models of care
• Workforce Scaling & Management
• Build and scale a reliable, high-quality network in Japan
• Partner with hiring teams to design and execute screening, assessment, and onboarding processes
• Establish systems for rostering, utilisation, and performance management
• Quality, Insights & Risk Management
• Monitor performance through audits, data analysis, and insights
• Lead incident and complaint management, including triage, escalation, and resolution
• Implement continuous quality improvement initiatives to enhance patient outcomes
• Develop scalable guardrails and safety protocols

Candidate Profile & Required Qualifications

To succeed in this role, Eucalyptus is seeking candidates who possess the following credentials, competencies, and mindset:

• Practitioner Collaboration & Leadership
• Act as the primary escalation point for Japanese prescribers and clinicians
• Foster strong collaboration between remote practitioners and internal teams
• Provide leadership, guidance, and ongoing support to practitioners
• A scalable and high-performing prescriber network in Japan
• Strong adherence to quality and safety standards
• Clear and effective governance frameworks tailored to Japan
• Seamless collaboration between clinical, operational, and commercial teams
• Established trust with local regulators, partners, and stakeholders
• Experience in operations and/or strategy in a rapidly scaling organisation
• Proven ability to build and scale teams or processes in a fast-paced environment
• Strong stakeholder management skills, with the ability to work across local and global teams

Workplace Culture, Mentorship & Benefits

Eucalyptus fosters a high-autonomy, patient-first culture backed by the scale of Hims & Hers:

• Obesity in Japan is often overlooked. Although the country is seen as a “slim nation,” the WHO recognises obesity for Asian populations from a BMI of 25 due to higher health risks at lower thresholds. Around 20% of adults receive obesity indicators during annual check-ups, yet many don’t get access to ongoing, supportive care.
• Euc is here to offer a more supportive path through:
• Thoughtful, evidence-based clinical care
• Ethical and responsible prescribing
• Accessible, affordable treatment options
• Warm, non-judgemental support for every patient

Remuneration & Transparency

Competitive Tokyo market compensation with full social insurances, commuting allowance, and bilingual team support.